Literature DB >> 19753111

Dual energy X-Ray absorptiometry body composition reference values from NHANES.

Thomas L Kelly1, Kevin E Wilson, Steven B Heymsfield.   

Abstract

In 2008 the National Center for Health Statistics released a dual energy x-ray absorptiometry (DXA) whole body dataset from the NHANES population-based sample acquired with modern fan beam scanners in 15 counties across the United States from 1999 through 2004. The NHANES dataset was partitioned by gender and ethnicity and DXA whole body measures of %fat, fat mass/height(2), lean mass/height(2), appendicular lean mass/height(2), %fat trunk/%fat legs ratio, trunk/limb fat mass ratio of fat, bone mineral content (BMC) and bone mineral density (BMD) were analyzed to provide reference values for subjects 8 to 85 years old. DXA reference values for adults were normalized to age; reference values for children included total and sub-total whole body results and were normalized to age, height, or lean mass. We developed an obesity classification scheme by using estabbody mass index (BMI) classification thresholds and prevalences in young adults to generate matching classification thresholds for Fat Mass Index (FMI; fat mass/height(2)). These reference values should be helpful in the evaluation of a variety of adult and childhood abnormalities involving fat, lean, and bone, for establishing entry criteria into clinical trials, and for other medical, research, and epidemiological uses.

Entities:  

Mesh:

Year:  2009        PMID: 19753111      PMCID: PMC2737140          DOI: 10.1371/journal.pone.0007038

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The National Health and Nutrition Examination Survey (NHANES) is a program designed to assess the health and nutritional status of adults and children in the United States. NHANES performs a continuous, nationally representative health survey of the civilian, non-institutionalized United States population, collecting data on about 5000 persons each year from interviews, physical examinations, and medical tests including bone densitometry. Previous NHANES surveys provided a widely accepted DXA proximal femur BMD database [1]. In 1999 NHANES began performing DXA whole body measurements on survey subjects 8 years old and older in three mobile examination centers. DXA whole body data from the mobile exam centers was compiled by the NHANES study group and released on the Center for Disease Control (CDC) website. Previous studies used the data to investigate age, gender, and ethnic differences in whole body and regional BMD [2] or compared percent body fat to BMI, waist circumference, and waist-to-stature ratio in adults [3]. We report here on an age, gender, and ethnicity-specific DXA body composition and bone mineral reference database developed from the NHANES survey data collected from 1999 to 2004. Additionally, we developed an obesity classification scheme by calculating the prevalences of well established BMI classification thresholds and generating similar thresholds for Fat Mass Index (FMI; fat mass/height2) [4]. These prevalence-matched FMI classifications should offer superior specificity because the index is based on fat mass, not body weight, which is composed of both fat and lean constituents. The reference data reported here should be helpful in detecting abnormalities in whole body bone and body composition, for establishing reference ranges, for epidemiological considerations (e.g., to establish the prevalence of obesity or sarcopenia), and for entry criteria into clinical trials.

Methods

Subjects

Reference curves were developed for the following three major U.S. ethnic groups: Non-Hispanic Whites (hereafter referred to as White), Non-Hispanic Blacks (hereafter referred to as Black), and Mexican Americans. There were not enough observations to develop reference data for other ethnic minorities. Blacks, Mexican Americans, low-income Whites, adolescents between 12 and 19 years old, and subjects 60 years old and older were oversampled to provide more reliable estimates for these groups [3]. Females were excluded from the DXA examination if a pregnancy test was positive at exam time or if they said they were pregnant. Subjects were also excluded if their reported weight exceeded the DXA scan table weight limit of 136 kg or if their reported height was greater than the DXA scan table length of 196 cm”.

DXA Measurements

The whole body DXA exams in NHANES were acquired according to the procedures recommended by the manufacturer on a QDR 4500A fan beam densitometer (Hologic, Inc., Bedford, MA). All subjects changed into paper gowns and were asked to remove all jewelry and other personal effects that could interfere with the DXA exam. The DXA exams were reviewed and analyzed by the University of California, San Francisco Department of Radiology Bone Density Group using industry standard techniques. Analysis of all exams was performed using Hologic Discovery software version 12.1 in its default configuration. Exams that contained artifacts which could affect the accuracy of the DXA results, such as prosthetic devices, implants or other extraneous objects had the regional and global DXA results for these exams set to missing in the dataset. The precision of the DXA instrument used in the NHANES study has been reported on elsewhere [5], [6], [7]. Body composition measurements are technology and calibration dependent and hence results provided by different instruments vary widely. The DXA instruments used in the NHANES survey employed the calibration proposed by Schoeller et al. [8], whereby DXA lean mass results were calibrated to lean mass measured in 7 independent studies utilizing total body water (4 studies), hydrodensitometry (1 study), and four compartment measures (2 studies). The seven independent studies involved a total of 1195 subjects (602 male, 593 female). The BMD and BMC results were calibrated by the DXA manufacturer and maintained by an internal reference system that periodically measures bone and soft tissue equivalent reference standards during the patient measurement. The NHANES data sets contained whole body DXA measurements of bone mineral content (BMC, g), areal bone mineral density (BMD, g/cm2), fat mass (g) and lean mass including BMC (g) and percent fat, calculated as (fat mass divided by total mass) ×100 along with demographic information for each subject. The above measurements were also available for a number of pre-defined anatomical regions, including the head, arms, legs, trunk, pelvic regions, sub-total whole body (excluding only the head) and whole body. From these whole body measures the following derivative values were calculated: FMI (fat mass/height2), lean mass/height2, appendicular lean mass/height2. For adults, only total body reference values and the above derivative reference values were generated. For children, (subjects less than 20 years of age), total body and sub-total body reference values and selected derivative reference values were generated. There is increasing realization that fat distribution may be as important as total fat mass, so two indices of fat mass distribution, %fat of the trunk divided by %fat of the legs and fat mass of the trunk divided by fat mass of the limbs (fat mass of arms plus legs) were included in this analysis for adults. These indices may have a role in defining metabolic syndrome or lipodystorphy [9], [10].

Statistical Methods

Our analysis used the DXA data sets released by NHANES on the Center for Disease Control website http://www.cdc.gov/nchs/about/major/nhanes/dxx/dxa.htm). To prevent bias in the survey due to the fact that the missing data was not completely random, missing data was multiply imputed at the National Center for Health Statistics as described in the technical documentation available on the above referenced website. The data was partitioned into subgroups according to gender and ethnicity. Ethnicity was self-reported and adjudicated by NHANES into the three major ethnicity groups reported on here (White, Black, and Mexican American). To reduce the complexity of the reference curve fitting procedure, we further divided the data into adult (ages 20–85) and pediatric (ages 8–19+) groups. The number of observations in each subgroup is provided in .
Table 1

Number of observations in the reference database by age, gender, and ethnicity.

Age GroupGenderWhitesBlacksMexican Americans
8 to 9Male819093
Female497551
10 to 11Male140196169
Female97123110
12 to 13Male186229250
Female144167141
14 to 15Male222292296
Female173213213
16 to 17Male238296308
Female154172171
18 to 20Male338422452
Female319333395
20 to 25Male235138160
Female323160239
25 to 30Male238100164
Female338127180
30 to 35Male241118138
Female350145149
35 to 40Male249114116
Female298139135
40 to 45Male292149164
Female260154174
45 to 50Male244125135
Female244148129
50 to 55Male29810172
Female28794100
55 to 60Male2077263
Female2047853
60 to 65Male248115166
Female263138168
65 to 70Male243112123
Female23893144
70 to 75Male28870105
Female23672105
75 to 80Male2255464
Female2066554
80 to 85Male2572333
Female2992832
85+Male1681817
Female1842525
TotalMale463828343088
Female466625592768
For adult subjects, DXA measures were modeled by gender and ethnicity using age as the independent variable. Whole body fat and lean mass measurements and appendicular lean mass were normalized to height2 as suggested by Heymsfield et al. [11]. For pediatric subjects the DXA measures were modeled against age, height, or lean mass as the independent variable. The development of skeletal reference values were based on the recommendations of the ICSD task force for Pediatric Official Positions paper [12]. Additional soft tissue reference values generated in pediatric subjects included total body %fat and lean mass/height2 (kg/m2). A curve fitting procedure called LMS (lmsChartMaker Pro Version 2.3) [13] was used to generate the reference curves because it is capable of handling the relatively common situation where the underlying reference data are skew, i.e. the data are not normally distributed. It does so by normalizing the underlying reference data by dividing the independent measure (e.g. age) into groups and then applying a power transformation which extends one tail of the distribution and contracts the other, eliminating skewness in the variable under analysis. A smooth curve is fitted to the normalizing power transformation for each age group, generating an optimum “L” (power) curve that normalizes the dependent measure, e.g. %fat, over the entire age range. The procedure also fits Median (M) and coefficient of variation (S) curves, and these three curves (L, M, and S) fully describe the reference data. We report the more commonly used population standard deviation, σ, which is S times M. The z-scores can be calculated by the following equation:orwhere X is the physical measurement (e.g. DXA Total Body BMD, DXA %fat, etc.), L is the power transformation, M is the median value, and σ is the population standard deviation [13]. Percentiles can be obtained from z-scores, e.g. z-scores of −1.881, −1.645, −0.674, 0, 0.674, 1.645, and 1.881 correspond to the 3rd, 5th, 25th, 50th, 75th, 95th, and 97th percentiles, respectively. As previously stated, the data were separated into pediatric and adult groups to simplify the curve fitting process and to lower the equivalent degrees of freedom required to fit a suitable curve to the reference data. For example, it was observed that very complex curves were required to produce a satisfactory model of BMC versus age in the entire population, due to the exponential BMC accrual observed in younger subjects combined with a consolidation phase of BMC in early adulthood and then a relatively modest decline in BMC that occurs during aging. When these two very different processes (growth and aging) were modeled independently, much simpler models could be employed with improved goodness of fit and decreased complexity. During the curve fitting process, the weighted observations from the NHANES data sets were fitted by selecting more parsimonious models over more complex models so long as the goodness of fit was similar, i.e. we tried to avoid over fitting the curves. Further, we employed careful visual inspection of the Q statistic, a plot of standardized residuals in which the data are split into groups and the non-random between group variations in the estimated moments of the z-scores are plotted against the equivalent degrees of freedom used to fit the curve. The Q-statistic was considered satisfactory at or below a value of 2 for the L, M, and S curves and if the fitted curve was reasonably smooth and plausible for the data being fitted, as recommended by the developers of LMS [13]. An obesity classification scheme based on FMI was developed by first calculating the prevalences of established WHO BMI classification thresholds (e.g. normal, overweight, obese) in the present NHANES survey data using “young normal adults” at age of 25. From these prevalence values for BMI, we then generated classification thresholds for FMI that gave the same prevalences as BMI in this population at age 25. In effect we have translated the WHO BMI thresholds into FMI equivalent values by matching the prevalences of the two indices at each classification cut-off point. The FMI classifications should misclassify fewer individuals because FMI is based on fat mass, not body weight, which contains both fat and lean components and therefore misclassifies some muscular subjects as overweight or obese.

Results

The number of observations in the reference database by age group, gender, and ethnicity is provided in Table 1. The reference curves developed from the whole body DXA measures and derivative values from the 2008 NHANES data set are provided in Table 2. Reference values for each of the DXA measures in Table 2 are provided in supplementary Table S1 through Table S20 by sex and ethnicity. Scatter plots with the fits including the mean, the 3rd and 97th percentiles superimposed upon the raw data values are provided in the supplementary Figure S1 through Figure S20 for adults and children.
Table 2

List of reference curves generated from the 2008 NHANES DXA whole body data set.

DXA MeasureIndependent VariableAge GroupSupplemental Table and Figure
Fat Mass/Height2 (FMI)AgeAdult OnlyS1
Total Body % FatAgeAdult and PediatricS2 and S9
% Fat Trunk/% Fat LegsAgeAdult OnlyS3
Trunk/Limb Fat Mass RatioAgeAdult OnlyS4
Lean Mass/Height2 AgeAdult and PediatricS5 and S10
Appendicular Lean Mass/Height2 AgeAdult OnlyS6
Total Body BMDAgeAdult and PediatricS7 and S11
Total Body BMCAgeAdult and PediatricS8 and S12
Sub-total Body BMD (excludes head)AgePediatric OnlyS13
Sub-total Body BMC (excludes head)AgePediatric OnlyS14
Total Body BMDHeightPediatric OnlyS15
Total Body BMCHeightPediatric OnlyS16
Sub-total Body BMD (excludes head)HeightPediatric OnlyS17
Sub-total Body BMC (excludes head)HeightPediatric OnlyS18
Total Lean MassHeightPediatric OnlyS19
Sub-total Body BMC (excludes head)Total Lean MassPediatric OnlyS20

For each whole body DXA measure in column 1, male and female reference curves for White, Black, and Mexican American subjects were modeled against the independent variable in column 2. Adult age range is 20 to 85 years; Pediatric age range is 8 to 20 years.

For each whole body DXA measure in column 1, male and female reference curves for White, Black, and Mexican American subjects were modeled against the independent variable in column 2. Adult age range is 20 to 85 years; Pediatric age range is 8 to 20 years. As expected, significant differences were observed between genders for the various measures and these differences varied with age. The median %fat increased monotonically with age from 17 to 85 in males, while in women it peaked at approximately age 65. Differences between ethnicities were more modest, and varied with gender. Black males had slightly less %fat than non-black males at all ages. Differences in %fat between non-black males and non-black females was about 11–12% and fairly constant with age; larger differences of 12–16% were observed between black males and black females and the differences were more variable with age. As can be seen from the scatter plots in the Supplementary Figures, some of the data were not only significantly skewed, but the degree of skewness and the standard deviation varied with the independent variable. The curve fitting method of LMS smoothly models both varying non-normal distributions and varying standard deviations to construct reference curves which accurately model the true distribution and variance of the underlying data. The LMS curve fitting procedure adjusts for skewness so that the percentile values and z-scores generated by the LMS values are robust when the data are not normally distributed. Statistical theory states that a properly fitted reference curve will generate z-scores very close to zero with a standard deviation very close to unity. Using the SAS system, we calculated z-scores for all subjects and all DXA measures in the NHANES dataset; average z-scores were very close to zero with standard deviations very close to unity for all fitted DXA measures, indicating that the LMS curve fitting procedure produced robust, unbiased fits to the underlying reference data. We employed the BMI classifications from the WHO technical report on the use and interpretation of anthropometry [14], [15] to establish similar classifications for FMI by calculating the prevalences at age 25 for each of the WHO BMI classification thresholds (e.g. mild thinness, normal, overweight, obese class 1, etc.) and then assigning FMI values with matching prevalences to each classification threshold. The FMI classification ranges were similar for the three ethnic groups even though the BMI classification prevalences varied widely (see Table 3). However, large differences in FMI thresholds were observed between genders, with women having higher FMI for all classification categories, requiring the use of gender-specific FMI thresholds. The final FMI classification thresholds in Table 4 were based on the values for White subjects in Table 3. Although the values for the three ethnic groups were similar, there were many more observations for White subjects and hence the use of these values should provide more robust classification estimates.
Table 3

FMI (kg/m2) thresholds with the same prevalence as a given BMI threshold at age 25.

SexEthnicityFMI matching BMI<16 (prevalence)FMI matching BMI<17 (prevalence)FMI matching BMI<18.5 (prevalence)FMI matching BMI>25 (prevalence)FMI matching BMI>30 (prevalence)FMI matching BMI>35 (prevalence)FMI matching BMI>40 (prevalence)
MWhite<1.9 (0.1%)<2.3 (0.5%)<2.9 (2.6%)>6.0 (55%)>8.9 (22%)>11.9 (8%)>15.0 (2.6%)
MBlack<1.7 (0.2%)<2.0 (0.7%)<2.5 (3.3%)>5.4 (54%)>8.1 (24%)>11.2 (11%)>14.4 (3.3%)
MMexican American<2.0 (<0.1%)<2.3 (0.1%)<3.0 (0.6%)>6.3 (59%)>9.2 (20%)>12.3 (6%)>15.4 (1.7%)
FWhite<3.5 (0.8%)<4.0 (2.2%)<4.9 (7%)>9.2 (47%)>12.9 (21%)>16.8 (9%)>20.6 (4.1%)
FBlack<3.4 (0.5%)<3.9 (1.1%)<4.7 (3.0%)>8.6 (70%)>11.9 (42%)>15.3 (22%)>18.7 (11%)
FMexican American<3.8 (0.1%)<4.3 (0.5%)<5.2 (2.2%)>9.4 (62%)>12.8 (29%)>16.1 (12%)>19.2 (4.6%)

The above FMI thresholds gave the same prevalence as BMI for each of the principal BMI classification cut-off points. FMI thresholds were similar among the ethnic groups even though their prevalences vary considerably.

Table 4

Fat Mass Index (kg/m2) classification ranges.

FMI ClassSevere Fat DeficitModerate Fat DeficitMild Fat DeficitNormalExcess FatObese Class IObese Class IIObese Class III
M<22 to <2.32.3 to <33–6>6 to 9>9 to 12>12 to 15>15
F<3.53.5 to <44 to <55–9>9 to 13>13 to 17>17 to 21>21

Classification ranges for FMI that match the prevalences of the WHO BMI classifications (see Table 3). Unlike BMI, FMI is a gender specific measure of fat not confounded by lean tissue.

The above FMI thresholds gave the same prevalence as BMI for each of the principal BMI classification cut-off points. FMI thresholds were similar among the ethnic groups even though their prevalences vary considerably. Classification ranges for FMI that match the prevalences of the WHO BMI classifications (see Table 3). Unlike BMI, FMI is a gender specific measure of fat not confounded by lean tissue.

Discussion

The lack of representative body composition reference values has limited their potential application in clinical and research settings. The current report provides the first reference values on a nationally representative NHANES data set acquired using well established DXA technology. These reference values should prove useful for many applications previously limited by inadequate or unavailable reference data. The NHANES reference values reported here are only directly compatible with Hologic fan beam DXA scanners operating software version 12.5 or higher utilizing the NHANES calibration. The NHANES reference data used in this study included multiply imputed data and this may be a limitation of the study. As with any reference database, the application of these data to generate diagnostic scores for a given patient or patient population should be performed with appropriate measure of forethought and caution. The reference data presented here may be useful in detecting skeletal and body composition abnormalities in children arising from a wide variety of conditions and chronic diseases including anorexia nervosa, growth hormone deficiency, glucocorticoid use, immobilization, cystic fibrosis, hypogonadism, thalassemia, malnutrition, weight management, chronic inflammatory diseases, endocrine disturbances, childhood cancer, transplantation, and other disorders [16]. Increasing numbers of children are being referred for DXA whole body measurements because of its ability to evaluate global and regional bone mineral and body composition. Total body less head (sub-total) whole body results are currently recommended by the ISCD for the evaluation of some childhood disorders [12]. Normalizing to height is appropriate in children with delayed growth and maturation. Furthermore, sub-total (whole body less head) BMD and BMC reference data are necessary because the head is disproportionately large in young children and may mask deficits at other skeletal sites. As a result, we developed whole body and sub-total BMD and BMC reference curves for subjects 8 to 20 years old normalized to both age and height. Height is an important body size adjustment in children because children mature at different rates and because many chronically ill children are small for their age. As a result, chronological age may not be the best indicator of a child's growth and development and therefore age-matched comparisons may not be appropriate. The International Society for Clinical Densitometry (ISCD) also recommends the use of a sufficiently large sample of the general population that takes into consideration gender, age, and ethnicity [17]. The present database meets all of these conditions through the use of gender, and ethnicity specific reference data from NHANES including DXA sub-total body measures normalized to age and to body size (height). We also developed total lean mass versus height and sub-total BMC versus lean mass reference curves for children, as suggested by the ISCD in its latest Official Positions Statement for Pediatric DXA (see www.iscd.org). These two additional curves should allow for the detection of abnormalities in lean mass accrual, e.g. in growth hormone deficient children, and for the detection of abnormalities in the bone-muscle unit, respectively, as suggested by Schoenau et al. [18]. NHANES did not collect information on pubertal development and therefore no adjustment to the reference values to account for delayed maturation was possible. As a result, clinicians should use caution when interpreting DXA measures in subjects with delayed or advanced maturation. In adults, we normalized both fat and lean mass by height2, just like BMI, which is simply weight divided by height2. Studies have shown that lean mass and weight scale with height to approximately the power of two, establishing an analytic framework for height-scaled indices [11]. The same study also found that fat mass scaled to height2, although the association was weaker. The present study confirmed this observation. We hypothesized that comparison of a subject's FMI value to healthy young normal FMI values may be useful in the diagnosis and management of clinical obesity, for identifying subjects with high obesity-disease risks, and for enrolling high risk subjects in clinical trials. However, while these cross sectional data enable this definition, whether this definition is useful and appropriate will have to be investigated in future studies which look at obesity related morbidity and outcomes. Defining thresholds in comparison to a young adult population has been adopted in the field of osteoporosis research (e.g. the bone mineral density T-score) and has proven itself a useful tool. Reference curves for appendicular lean mass divided by height2 were developed because this DXA measure is a good surrogate for skeletal muscle mass and a possible index of sarcopenia [19]. DXA is the only widely available technology capable of providing regional measures of fat and lean mass, and it has been shown that fat and lean distribution may predict health outcomes. A study of elderly subjects [13] demonstrated that sarcopenia, defined as appendicular skeletal muscle mass (kg/height2) less than two standard deviations below the mean of a young reference group, predicted self-reported physical disability in elderly men and women independent of other covariates such as age, obesity, ethnicity, and income level. In the present NHANES database fat comprises approximately 24% of body weight in males and 38% in females at age 25. Although these %fat values may seem quite high, they are consistent with the %fat reference ranges reported by NHANES in the 1988–1994 survey that utilized bioimpedence analysis. In the 1988–1994 survey, the average male and female %fat values at age 25 were 23% and 34%, respectively [20]. The slightly higher %fat values reported here are consistent with the secular trend of increasing weight and BMI in adult Americans. However, the two studies used different technologies to measure %fat, so direct comparisons between the two studies are difficult to interpret. DXA is capable of separating body mass into fat and lean components, thereby permitting the evaluation of fat mass without the confounding influence of other tissue constituents. We propose the use of FMI (fat mass/height2) as a measure of abnormally low or excess fat mass because FMI evaluates only the fat mass component of body weight. Using FMI, abnormalities in fat mass can be assessed without interference from other unrelated components such as excesses or deficits of muscle or water. Our data reveal %fat and FMI increasing up until about age 80 in men and age 65 in women. Increasing adiposity is an unhealthy trend and hence comparing DXA measurements of %fat and FMI to age-matched peers may not be the most appropriate approach. We postulate that it may be better to compare adults to young normal gender and ethnicity-matched subjects at age 25. For example, using the median value of %fat for non-Hispanic white males at age 25 as an arbitrary “healthy target”, only 25% of 45 year old non-Hispanic white males are at or below this target, and by age 69, the number falls to less than 10%. Though alarming, the low percentage of subjects at or below this healthy %fat target probably provides a more realistic assessment of %fat and FMI levels versus comparing subjects to age-matched controls, where by definition 50% of subjects would appear “normal”. We selected from the present data a young adult group with a BMI between 18.5 and 25 to establish reasonably robust reference values for “normal” FMI. Following this same methodology, we developed classifications for FMI by selecting values for FMI that matched the population prevalence of the WHO BMI classifications [14] in young adults at age 25. For example, at age 25 a FMI value of greater than 6 kg/m2 for men and 9 kg/m2 for women matches the same prevalence value of “overweight” obtained with a BMI of 25, the BMI cut-off point for “overweight”. Similarly, FMI values of greater than or equal to 9 kg/m2 for men and 13 kg/m2 for women defines the same obesity prevalence as a BMI of 30 in this population. Kyle et al. [21] employed similar methodology to generate FMI classifications corresponding to low, normal, overweight, and obese BMI categories. Note that although the same prevalences were used for each classification, FMI and BMI actually classify different subjects into the various categories. Were this not so, it would not be possible for one method to have an advantage over the other. Gallagher et al. [22] used the same approach to generate guidelines for healthy percent fat ranges based on BMI. A major shortcoming of BMI is that it provides a measure of excess weight, not excess fat. Another obvious limitation of BMI is that it does not account for gender or ethnicity. Table 3 clearly demonstrates that BMI prevalences are heavily influenced by both gender and ethnicity. At age 25, the FMI data in Table 3 indicates that there are substantial differences in adiposity between genders, with mean values for women ranging from 8.9 to 10.9 kg/m2 and mean values for males between 5.6 to 6.8 kg/m2 for the three ethnic groups. From these data it appears likely that lacking gender or ethnicity adjustments, BMI may be overestimating obesity in some groups and underestimating it in others. Furthermore, subjects with a high degree of muscularity, e.g. body builders, are often misclassified as “overweight” or “obese” by BMI; these same subjects would probably not fall into an abnormal classification range with FMI because their excess weight is mostly lean mass. Percent body fat (%fat) measurements are also complicated by increased muscularity, but here the bias is in the opposite direction, as increases in muscle mass offset increases in fat mass, making a %fat measurement appear more or less normal. We suggest that using these proposed FMI values for overweight and obese classifications will result in fewer misclassifications than either BMI or %fat. The FMI classifications in Table 4 should be considered guidelines that may misclassify fewer individuals than BMI because they are based on fat mass instead of weight. It is also worth noting that other technologies which measure fat mass will have to be calibrated to the DXA systems used in this study in order to make uses of these FMI classifications. Whether or not the use of the proposed FMI classification scheme will confer benefits over BMI in terms of predicting obesity-related morbidity or mortality will have to be investigated in future studies. The FMI classifications presented here are based on prevalence data, not disease risk, and therefore the clinical utility of the FMI classification scheme will not be known until data relating disease risk to FMI becomes available. Fat Mass/Height2 (kg/m2) vs. Age in adults. (0.34 MB PDF) Click here for additional data file. Percent Fat (%) vs. Age in adults. (0.31 MB PDF) Click here for additional data file. % Fat Trunk/%Fat Legs vs. Age in adults. (0.34 MB PDF) Click here for additional data file. Trunk to Limb Fat Mass Ratio vs. Age in adults. (0.55 MB PDF) Click here for additional data file. Lean Mass/Height2 (kg/m2) vs. Age in adults. (0.34 MB PDF) Click here for additional data file. Appendicular Lean Mass/Height2 (kg/m2) vs. Age in adults. (0.30 MB PDF) Click here for additional data file. Total Body BMD (g/cm2) vs. Age in adults. (0.31 MB PDF) Click here for additional data file. Total Body BMC (g) vs. Age in adults. (0.57 MB PDF) Click here for additional data file. Percent Fat (%) vs. Age in pediatrics. (0.18 MB PDF) Click here for additional data file. Lean Mass/Height2 (kg/m2) vs. Age in adults. (0.20 MB PDF) Click here for additional data file. Total Body BMD (g/cm2) vs. Age in Pediatrics. (0.22 MB PDF) Click here for additional data file. Total Body BMC (g) vs. Age in pediatrics. (0.23 MB PDF) Click here for additional data file. Sub-total Body BMD (g/cm2) vs. Age in Pediatrics. (0.51 MB PDF) Click here for additional data file. Sub-total Body BMC (g) vs. Age in pediatrics. (0.23 MB PDF) Click here for additional data file. Total Body BMD (g/cm2) vs. Height (cm) in pediatrics. (0.51 MB PDF) Click here for additional data file. Total Body BMC (g) vs. Height (cm) in pediatrics. (0.24 MB PDF) Click here for additional data file. Sub-total Body BMD (g/cm2) vs. Height (cm) in pediatrics. (0.24 MB PDF) Click here for additional data file. Sub-total BMC (g) vs. Height (cm) in pediatrics. (0.25 MB PDF) Click here for additional data file. Total Lean Mass (g) vs. Height (cm) in pediatrics. (0.25 MB PDF) Click here for additional data file. Sub-total BMC (g) vs. Total Lean Mass (g) in pediatrics. (0.27 MB PDF) Click here for additional data file. Fat Mass/Height2 (kg/m2) vs. Age in adult subjects. (0.08 MB DOC) Click here for additional data file. %Fat (%) vs. Age in adult subjects. (0.08 MB DOC) Click here for additional data file. %Fat Trunk/%Fat Legs vs. Age in adult subjects. (0.08 MB DOC) Click here for additional data file. Trunk to Limb Fat Mass Ratio vs. Age in Adult subjects. (0.08 MB DOC) Click here for additional data file. Lean Mass/Height2 (kg/m2) vs. Age in adult subjects. (0.08 MB DOC) Click here for additional data file. Appendicular Lean Mass/Height2 (kg/m2) vs. Age in adult subjects. (0.08 MB DOC) Click here for additional data file. Total Body BMD (g/cm2) vs. Age in adult subjects. (0.08 MB DOC) Click here for additional data file. Total Body BMC (g) vs. Age in adult subjects. (0.08 MB DOC) Click here for additional data file. %Fat (%) vs. Age in pediatric subjects. (0.05 MB DOC) Click here for additional data file. Lean Mass/Height2 (kg/m2) vs. Age in pediatric subjects. (0.05 MB DOC) Click here for additional data file. Total Body BMD (g/cm2) vs. Age in pediatric subjects. (0.05 MB DOC) Click here for additional data file. Total Body BMC (g) vs. Age in Pediatric subjects. (0.05 MB DOC) Click here for additional data file. Sub-total Body BMD (g/cm2) vs. Age in pediatric subjects. (0.05 MB DOC) Click here for additional data file. Sub-total Body BMC (g) vs. Age in pediatric subjects. (0.05 MB DOC) Click here for additional data file. Total Body BMD (g/cm2) vs. Height (cm) in pediatric subjects. (0.08 MB DOC) Click here for additional data file. Total Body BMC (g) vs. Height (cm) in pediatric subjects. (0.09 MB DOC) Click here for additional data file. Sub-total Body BMD (g/cm2) vs. Height (cm) in pediatric subjects. (0.08 MB DOC) Click here for additional data file. Sub-total BMC (g) vs. Height (cm) in pediatric subjects. (0.08 MB DOC) Click here for additional data file. Total Lean Mass (g) vs. Height (cm) in pediatric subjects. (0.08 MB DOC) Click here for additional data file. sub-total BMC (g) vs. Total Lean Mass (g) in pediatric subjects. (0.09 MB DOC) Click here for additional data file.
  22 in total

Review 1.  The "muscle-bone unit" in children and adolescents.

Authors:  E Schoenau; H M Frost
Journal:  Calcif Tissue Int       Date:  2002-04-19       Impact factor: 4.333

2.  Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index.

Authors:  D Gallagher; S B Heymsfield; M Heo; S A Jebb; P R Murgatroyd; Y Sakamoto
Journal:  Am J Clin Nutr       Date:  2000-09       Impact factor: 7.045

3.  Body composition estimates from NHANES III bioelectrical impedance data.

Authors:  W C Chumlea; S S Guo; R J Kuczmarski; K M Flegal; C L Johnson; S B Heymsfield; H C Lukaski; K Friedl; V S Hubbard
Journal:  Int J Obes Relat Metab Disord       Date:  2002-12

4.  Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status.

Authors:  T B VanItallie; M U Yang; S B Heymsfield; R C Funk; R A Boileau
Journal:  Am J Clin Nutr       Date:  1990-12       Impact factor: 7.045

5.  Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women.

Authors:  Michele Iannuzzi-Sucich; Karen M Prestwood; Anne M Kenny
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2002-12       Impact factor: 6.053

6.  Body composition interpretation. Contributions of the fat-free mass index and the body fat mass index.

Authors:  Ursula G Kyle; Yves Schutz; Yves M Dupertuis; Claude Pichard
Journal:  Nutrition       Date:  2003 Jul-Aug       Impact factor: 4.008

7.  Age, gender, and race/ethnic differences in total body and subregional bone density.

Authors:  A C Looker; L J Melton; T Harris; L Borrud; J Shepherd; J McGowan
Journal:  Osteoporos Int       Date:  2008-12-02       Impact factor: 4.507

8.  Updated data on proximal femur bone mineral levels of US adults.

Authors:  A C Looker; H W Wahner; W L Dunn; M S Calvo; T B Harris; S P Heyse; C C Johnston; R Lindsay
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

9.  Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

10.  A comparison of goodness of fit tests for age-related reference ranges.

Authors:  H Pan; T J Cole
Journal:  Stat Med       Date:  2004-06-15       Impact factor: 2.373

View more
  359 in total

1.  Relationships between body composition analysis measures in Greek women and US white women.

Authors:  Stavroula J Theodorou; Daphne J Theodorou; John Kalef-Ezra; Andreas Fotopoulos; Niki Agnantis; Agathocles Tsatsoulis; Konstantinos Tsampoulas
Journal:  Rheumatol Int       Date:  2014-11-01       Impact factor: 2.631

2.  Low skeletal muscle mass associates with low femoral neck strength, especially in older Korean women: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV).

Authors:  B-J Kim; S H Ahn; H M Kim; S H Lee; J-M Koh
Journal:  Osteoporos Int       Date:  2014-11-13       Impact factor: 4.507

3.  An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy.

Authors:  Abhimanyu Garg; Maria Dolores Hernandez; Ana Berta Sousa; Lalitha Subramanyam; Laura Martínez de Villarreal; Heloísa G dos Santos; Oralia Barboza
Journal:  J Clin Endocrinol Metab       Date:  2010-06-09       Impact factor: 5.958

4.  Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial.

Authors:  Helen M Pappa; Tracee M Saslowsky; Rajna Filip-Dhima; Diane DiFabio; Hajar Hassani Lahsinoui; Apurva Akkad; Richard J Grand; Catherine M Gordon
Journal:  Am J Gastroenterol       Date:  2011-04-26       Impact factor: 10.864

5.  Prediction of whole-body and segmental body composition by bioelectrical impedance in morbidly obese subjects.

Authors:  Amanda Jiménez; Wilberto Omaña; Lílliam Flores; María José Coves; Diego Bellido; Verónica Perea; Josep Vidal
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

6.  Bone mineral density and body composition of South African cricketers.

Authors:  Lisa K Micklesfield; Janine Gray; Mogammad S Taliep
Journal:  J Bone Miner Metab       Date:  2011-09-21       Impact factor: 2.626

7.  Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation.

Authors:  Hiroto Inaba; Jie Yang; Sue C Kaste; Christine M Hartford; Megan S Motosue; Wassim Chemaitilly; Brandon M Triplett; David R Shook; Ching-Hon Pui; Wing Leung
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

8.  Demographic and socioeconomic correlates of adiposity assessed with dual-energy X-ray absorptiometry in US children and adolescents.

Authors:  Nguyen T Tuan; Nancy F Butte; Youfa Wang
Journal:  Am J Clin Nutr       Date:  2012-10-03       Impact factor: 7.045

9.  Change in body composition during a weight loss trial in obese adolescents.

Authors:  E P Parks; B Zemel; R H Moore; R I Berkowitz
Journal:  Pediatr Obes       Date:  2013-02-05       Impact factor: 4.000

10.  Reproducibility of jumping mechanography and traditional measures of physical and muscle function in older adults.

Authors:  B Buehring; D Krueger; E Fidler; R Gangnon; B Heiderscheit; N Binkley
Journal:  Osteoporos Int       Date:  2014-12-09       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.